dermal
-
Biologics
AlloSource Launches AlloMend Duo Acellular Dermal Matrix, A Natural Solution For Non-Directional Implantation In Soft Tissue Reconstruction
CENTENNIAL, Colo., May 25, 2023 /PRNewswire/ — AlloSource®, one of the largest nonprofit allograft providers in the U.S. creating innovative cellular and…
Read More » -
Biologics
MTF Biologics Unveils New Tissue Form: AlloPatch® Pliable Meshed – Acellular Human Reticular Dermal Allograft
Innovative allograft offers new treatment option for diabetic foot ulcers and venous leg ulcers EDISON, N.J., April 17, 2023–(BUSINESS WIRE) —MTF…
Read More » -
Biologics
AlloSource Launches Allomend Extra-large Acellular Dermal Matrix
New dermal graft has the largest footprint within the AlloMend product line to support demanding soft tissue applications in plastic…
Read More » -
Biologics
Fuse Medical, Inc. Announces Official Launch of FuseChoice™ Dermal Matrix
September 9, 2021 RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”), an emerging manufacturer and distributor of…
Read More » -
Biologics
AlloSource Launches AlloMend Ultra-Thick Acellular Dermal Matrix
New allograft is the thickest in the AlloMend product line to support demanding soft tissue applications CENTENNIAL, Colo., Aug. 11, 2021 /PRNewswire/…
Read More » -
Recon
HSS Study: Good Outcomes After Arthroscopic Shoulder Superior Capsular Reconstruction
by Elizabeth Hofheinz, M.P.H., M.Ed. A group of researchers from Hospital for Special Surgery (HSS) in New York has explored…
Read More » -
Biologics
Integra LifeSciences Organizes Hands-on Wound Workshop on Best Practices for Omnigraft® Dermal Regeneration Matrix and PriMatrix® Dermal Repair Scaffold at Symposium on Advanced Wound Care (SAWC) Fall Meeting
PLAINSBORO, N.J., Oct. 17, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) recently organized a hands-on regenerative wound management workshop…
Read More » -
Hospitals
Integra LifeSciences Receives FDA Approval for Integra® Omnigraft™ Dermal Regeneration Matrix, Clearing the Way for Commercial Release
PLAINSBORO, N.J., May 11, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today…
Read More » -
Biologics
SpinalCyte, LLC Announces Final Results From Phase II Animal Trials Using Human Dermal Fibroblast Transplantation for Intervertebral Disc Degeneration
HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on regrowth of the spinal disc nucleus using Human Dermal…
Read More » -
Extremities
Integra LifeSciences Receives FDA Approval of Integra® Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU)
PLAINSBORO, N.J., Jan. 07, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that the United States Food and Drug…
Read More »